OpenClaw Plugs Into ChatGPT, Unity AI Open Beta, RSI by 2028, AI Designs Antibiotic

Sam Altman's OpenClaw platform has successfully integrated ChatGPT capabilities whilst simultaneously blocking access to Anthropic's Claude agent. This development highlights the growing competition between AI platforms as they seek to establish exclusive partnerships and control access to leading language models. Unity AI has launched its open beta featuring Claude Code integration and Cursor MCP (Model Context Protocol) support. The gaming engine company's foray into AI tooling represents a significant expansion of its platform capabilities, potentially transforming how developers create and iterate on interactive experiences. The inclusion of MCP support suggests Unity is positioning itself as a comprehensive AI development environment. Former OpenAI policy director Jack Clark has offered a provocative prediction, giving recursive self-improvement in AI systems a "coin flip plus ten percent" chance of occurring by 2028. This 60% probability assessment for achieving artificial general intelligence through self-improving systems reflects growing confidence amongst AI researchers that transformative capabilities may emerge within the next four years. Meanwhile, in a breakthrough for drug discovery, SyntheMol-RL has successfully designed a new antibiotic capable of defeating MRSA (methicillin-resistant Staphylococcus aureus) in laboratory tests. This achievement demonstrates AI's potential to address critical medical challenges, with the system's reinforcement learning approach proving effective at molecular design for combating antibiotic-resistant pathogens.